GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Succeeder Technology Inc (SHSE:688338) » Definitions » Other Operating Expense

Beijing Succeeder Technology (SHSE:688338) Other Operating Expense : ¥33.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Succeeder Technology Other Operating Expense?

Beijing Succeeder Technology's Other Operating Expense for the three months ended in Sep. 2024 was ¥-17.9 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥33.0 Mil.

Beijing Succeeder Technology's quarterly Other Operating Expense increased from Mar. 2024 (¥-0.3 Mil) to Jun. 2024 (¥20.5 Mil) but then declined from Jun. 2024 (¥20.5 Mil) to Sep. 2024 (¥-17.9 Mil).

Beijing Succeeder Technology's annual Other Operating Expense increased from Dec. 2021 (¥27.8 Mil) to Dec. 2022 (¥28.6 Mil) and increased from Dec. 2022 (¥28.6 Mil) to Dec. 2023 (¥29.4 Mil).


Beijing Succeeder Technology Other Operating Expense Historical Data

The historical data trend for Beijing Succeeder Technology's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Succeeder Technology Other Operating Expense Chart

Beijing Succeeder Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial 24.31 24.99 27.78 28.61 29.39

Beijing Succeeder Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.54 30.63 -0.26 20.47 -17.88

Beijing Succeeder Technology Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥33.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Succeeder Technology Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Beijing Succeeder Technology's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Succeeder Technology Business Description

Traded in Other Exchanges
N/A
Address
Innovation Road, No. 1, Xingchang Road, Block 1A, No. 27, Science and Technology Park, 3rd Floor, Building 1, Changping District, East District, East District, Beijing, CHN, 102200
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
Executives
Le Jia Min Core technical personnel
Yu Song Yan Core technical personnel
Li Gang Core technical personnel
Zhang Ying Supervisors
Liang Yun Bo Core technical personnel
Zhang Jia Hong senior management
Li Guo Directors, senior managers
Ding Zhong Hui Directors, senior managers, core technical personn
Gu Xiao Feng Directors, senior managers
Wu Tong Director
Wu Shi Ming Director
Pei Yan Bin senior management
Wang Xiao Qing Supervisors
Zhang Chao Hui Director

Beijing Succeeder Technology Headlines

No Headlines